Position in NVS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$4,448,810
+$275,680 QoQ
Shares Held
28,387
+3.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.46%
of 13F equity value
Holder Rank
#283
of 1,603 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pegasus Asset Management, Inc. holds $17,244,818 across 4 Drug Manufacturers - General names. NVS ranks #2 (25.8% of the industry book) .
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,448,810 | 28,387 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $4,173,130 | 27,320 | Shares | Sole | 2026-04-21 | |
| No filing history on record for this holder in this stock. | ||||||